Stem cell product XSTEM in clinical studies

The Swedish biopharma company Xintela is receiving a lot of attention for its stem cell product platform XSTEMÒ and its stem cell therapies in development. XSTEM is now in clinical development for the treatment of knee osteoarthritis and difficult-to-heal venous leg ulcers. »